Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Scinai Immunotherapeutics...

    NASDAQ: SCNI · Real-Time Price · USD
    2.18
    -0.04 (-1.80%)
    At close: Jun 16, 2025, 3:59 PM
    2.20
    0.96%
    Pre-market: Jun 17, 2025, 06:57 AM EDT

    Scinai Immunotherapeutics Statistics

    Share Statistics

    Scinai Immunotherapeutics has 213 shares outstanding. The number of shares has increased by 46.73% in one year.

    Shares Outstanding

    n/a
    		 213

    Shares Change (YoY)

    n/a
    		 46.73%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 208

    Failed to Deliver (FTD) Shares

    n/a
    		 1,479

    FTD / Avg. Volume

    n/a
    		 0.41%

    Short Selling Information

    The latest short interest is 462, so 0.05% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 462

    Short % of Shares Out

    n/a
    		 0.05%

    Short % of Float

    n/a
    		 0.16%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 5.63 and the forward PE ratio is null. Scinai Immunotherapeutics's PEG ratio is -0.04.

    PE Ratio

    n/a
    		 5.63

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 41.05

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 -0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Scinai Immunotherapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    Current Ratio

    n/a
    		 0

    Quick Ratio

    n/a
    		 0

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 2.61

    Debt / FCF

    n/a
    		 -2.05

    Interest Coverage

    n/a
    		 -6

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $21,225.81

    Profits Per Employee

    n/a
    		 $154,709.68

    Employee Count

    n/a
    		 31

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -61.07% in the last 52 weeks. The beta is 2.09, so Scinai Immunotherapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.09

    52-Week Price Change

    n/a
    		 -61.07%

    50-Day Moving Average

    n/a
    		 2.54

    200-Day Moving Average

    n/a
    		 3.22

    Relative Strength Index (RSI)

    n/a
    		 40.09

    Average Volume (20 Days)

    n/a
    		 356,639

    Income Statement

    In the last 12 months, Scinai Immunotherapeutics had revenue of 658K and earned 4.8M in profits. Earnings per share was 5.99.

    Revenue

    n/a
    		 658K

    Gross Profit

    n/a
    		 -580K

    Operating Income

    n/a
    		 -8.64M

    Net Income

    n/a
    		 4.8M

    EBITDA

    n/a
    		 7.87M

    EBIT

    n/a
    		 6.22M

    Earnings Per Share (EPS)

    n/a
    		 5.99
    Full Income Statement

    Balance Sheet

    The company has 4.87M in cash and 20.56M in debt, giving a net cash position of -15.69M.

    Cash & Cash Equivalents

    n/a
    		 4.87M

    Total Debt

    n/a
    		 20.56M

    Net Cash

    n/a
    		 -15.69M

    Retained Earnings

    n/a
    		 -122.33M

    Total Assets

    n/a
    		 12.26M

    Working Capital

    n/a
    		 225K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.38M and capital expenditures -637K, giving a free cash flow of -10.02M.

    Operating Cash Flow

    n/a
    		 -9.38M

    Capital Expenditures

    n/a
    		 -637K

    Free Cash Flow

    n/a
    		 -10.02M

    FCF Per Share

    n/a
    		 n/a
    Full Cash Flow Statement

    Margins

    Gross margin is -88.15%, with operating and profit margins of -1312.77% and 728.88%.

    Gross Margin

    n/a
    		 -88.15%

    Operating Margin

    n/a
    		 -1312.77%

    Pretax Margin

    n/a
    		 728.88%

    Profit Margin

    n/a
    		 728.88%

    EBITDA Margin

    n/a
    		 1195.59%

    EBIT Margin

    n/a
    		 -1312.77%

    FCF Margin

    n/a
    		 -1522.64%

    Dividends & Yields

    SCNI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SCNI.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 21, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 May 21, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -11.84

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist